What's Going On With HCW Biologics Stock Monday?

HCW Biologics, Inc. (NASDAQ:HCWB) shares are trading higher on Monday after the company announced clearance from the Food and Drug Administration (FDA) for its Phase 1 trial of HCW9302.

The Details: The company’s HCW9302 is a potential treatment for moderate-to-severe alopecia areata, which is an autoimmune disease. Currently, there are no curative FDA-approved treatments for the disease.

The Phase 1 trial aims to establish a safe and effective dose of HCW9302. If successful, the company will ...

Full story available on Benzinga.com